Status | Study |
Recruiting |
Study Name: Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy Condition: Chronic Central Serous Chorioretinopathy Date: 2017-03-02 Interventions: Drug: Eplerenone |
Enrolling by invitation |
Study Name: Treatment Trial for Acute Central Serous Chorioretinopathy Condition: Acute Central Serous Chorioretinopathy Date: 2016-05-23 Interventions: Device: 577-MPL All treatments |
Completed |
Study Name: Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population Condition: Chronic Central Serous Chorioretinopathy Date: 2015-05-26 Interventions: Drug: Inspra (eplerenone) |
Recruiting |
Study Name: Short-Term Oral Mifepristone for Central Serous Chorioretinopathy Condition: Central Serous Chorioretinopathy Date: 2015-01-29 Interventions: Drug: Mifepristone Drug: Placebo |
Not yet recruiting |
Study Name: A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy Condition: Central Serous Chorioretinopathy Date: 2014-08-11 Interventions: Drug: Eplerenone Drug: Maltodextrin |
Completed |
Study Name: Eplerenone for the Treatment of Central Serous Chorioretinopathy Condition: Central Serous Chorioretinopathy Date: 2013-11-15 Interventions: Drug: 25mg Eplerenone Patients |
Completed |
Study Name: Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy Condition: Central Serous Chorioretinopathy Date: 2013-11-06 Interventions: Device: Micropulse Laser Treatment Other Names: Micropulse 577nm |
Completed |
Study Name: Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy Condition: Central Serous Chorioretinopathy Date: 2013-10-21 Interventions: Drug: Intravitreal Aflibercept injection |
Recruiting |
Study Name: Eplerenone for Central Serous Chorioretinopathy Condition: Central Serous Chorioretinopathy Date: 2013-03-25 Interventions: Drug: Eplerenone 50mg All patients will receive the same dose of eplerenone. |
Recruiting |
Study Name: Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy Condition: Chronic Central Serous Chorioretinopathy Date: 2013-02-21 Interventions: Procedure: Half-dose photodynamic therapy (PDT) |